ZA200808851B - Pharmaceutical composition containing clopidogrel camphorsulfonate or polymorphic forms thereof - Google Patents
Pharmaceutical composition containing clopidogrel camphorsulfonate or polymorphic forms thereofInfo
- Publication number
- ZA200808851B ZA200808851B ZA200808851A ZA200808851A ZA200808851B ZA 200808851 B ZA200808851 B ZA 200808851B ZA 200808851 A ZA200808851 A ZA 200808851A ZA 200808851 A ZA200808851 A ZA 200808851A ZA 200808851 B ZA200808851 B ZA 200808851B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- composition containing
- polymorphic forms
- containing clopidogrel
- clopidogrel camphorsulfonate
- Prior art date
Links
- XEENARPWPCQXST-DDJQTTAYSA-N C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C.C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C.C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl XEENARPWPCQXST-DDJQTTAYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020060024610A KR20070094230A (ko) | 2006-03-17 | 2006-03-17 | 클로피도그렐 캄파술폰산염 또는 이의 결정다형을 함유하는약학 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200808851B true ZA200808851B (en) | 2009-12-30 |
Family
ID=38522614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200808851A ZA200808851B (en) | 2006-03-17 | 2007-03-15 | Pharmaceutical composition containing clopidogrel camphorsulfonate or polymorphic forms thereof |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090209576A1 (xx) |
| EP (1) | EP1996197A1 (xx) |
| KR (1) | KR20070094230A (xx) |
| AU (1) | AU2007227919B2 (xx) |
| WO (1) | WO2007108604A1 (xx) |
| ZA (1) | ZA200808851B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI22383A (sl) * | 2006-09-22 | 2008-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
| IL166593A0 (en) * | 2002-08-02 | 2006-01-15 | Racemization and enantiomer separation of clopidogrel |
-
2006
- 2006-03-17 KR KR1020060024610A patent/KR20070094230A/ko not_active Ceased
-
2007
- 2007-03-15 EP EP07745581A patent/EP1996197A1/en not_active Withdrawn
- 2007-03-15 ZA ZA200808851A patent/ZA200808851B/xx unknown
- 2007-03-15 WO PCT/KR2007/001278 patent/WO2007108604A1/en not_active Ceased
- 2007-03-15 US US12/293,357 patent/US20090209576A1/en not_active Abandoned
- 2007-03-15 AU AU2007227919A patent/AU2007227919B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007108604A1 (en) | 2007-09-27 |
| US20090209576A1 (en) | 2009-08-20 |
| AU2007227919A1 (en) | 2007-09-27 |
| KR20070094230A (ko) | 2007-09-20 |
| AU2007227919B2 (en) | 2009-09-24 |
| EP1996197A1 (en) | 2008-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL195861A0 (en) | Thienopyrimidine derivatives and pharmaceutical compositions containing the same | |
| IL194762A0 (en) | Pharmaceutical compounds | |
| EP2001498A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EP2001497A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB0713625D0 (en) | Pharmaceutical compositions | |
| EP2124556A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB0608820D0 (en) | Pharmaceutical compounds | |
| IL194853A0 (en) | Triaryl compounds and derivatives thereof | |
| EP1996209A4 (en) | CONTRACEPTIVE COMPOSITION | |
| EP2124959A4 (en) | PHARMACEUTICAL COMPOSITION | |
| GB0801341D0 (en) | Pharmaceutical compositions containing clopidogrel bisulfate | |
| SI1976522T1 (sl) | Farmacevtski sestavek, ki vsebuje montelukast | |
| ZA200808851B (en) | Pharmaceutical composition containing clopidogrel camphorsulfonate or polymorphic forms thereof | |
| GB0608176D0 (en) | Pharmaceutical Compounds | |
| GB0608184D0 (en) | Pharmaceutical compounds | |
| HU0600097D0 (en) | Pharmaceutical composition comprising tacrolimus | |
| GB0608175D0 (en) | Pharmaceutical Compounds | |
| GB0608264D0 (en) | Pharmaceutical compounds | |
| GB0625682D0 (en) | Pharmaceutical compounds | |
| GB0622892D0 (en) | Pharmaceutical compounds | |
| GB0612696D0 (en) | Pharmaceutical composition | |
| GB0600032D0 (en) | Pharmaceutical composition | |
| GB0617578D0 (en) | Pharmaceutical composition | |
| GB0608185D0 (en) | Pharmaceutical Compounds | |
| GB0625668D0 (en) | Pharmaceutical compounds |